| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |